Ferritin-Bearing T-Lymphocytes in Breast Cancer Patients
Author Information
Author(s): K. Pattanapanyasat, T.G. Hoy, A. Jacobs, S. Courtney, D.J.T. Webster
Primary Institution: University of Wales College of Medicine
Hypothesis
The study aims to investigate the relationship between ferritin-bearing T-lymphocytes and the clinical status of breast cancer patients.
Conclusion
Breast cancer patients have a significantly higher number of ferritin-bearing T-cells compared to normal controls, but this increase is not related to the clinical stage of the disease.
Supporting Evidence
- Ferritin levels in breast cancer patients are significantly higher than in normal subjects.
- Seventy to eighty percent of cancer patients have an increased percentage of ferritin-bearing T-cells.
- There is no significant difference in T-cell levels between normal and breast disease patients.
Takeaway
Doctors found that patients with breast cancer have more special immune cells that carry ferritin, a protein that stores iron, but this doesn't change with how advanced the cancer is.
Methodology
Flow cytometry was used to measure ferritin and other T-cell surface markers in patients with breast cancer and controls.
Limitations
The study does not clarify the specific significance of ferritin on lymphocyte surfaces in cancer patients.
Participant Demographics
Patients were aged between 34 and 87 years, with approximately half younger than 55; included 50 breast cancer patients, 20 with benign disease, and 20 healthy controls.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% confidence limits for normal group
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website